Aura Biosciences, Inc. AURA Income Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $6.23M-25.3% | $6.63M-29.7% | $7.12M-28.8% | $7.56M-22.2% | $8.34M-10.2% | ||
| $94.92M+19.3% | $90.3M+23.2% | $90.74M+27.4% | $85.6M+22.9% | $79.59M+17.3% | ||
| $23.71M+2.0% | $22.49M-1.4% | $22.62M+3.6% | $23.09M+11.5% | $23.24M+16.3% | ||
| $118.62M+15.4% | $112.79M+17.4% | $113.36M+21.8% | $108.69M+20.3% | $102.84M+17.0% | ||
| -$118.62M-15.4% | -$112.79M-17.4% | -$113.36M-21.8% | -$108.69M-20.3% | -$102.84M-17.0% | ||
| $6.33M-23.1% | $6.71M-27.9% | $7.01M-30.6% | $7.44M-24.4% | $8.23M-12.5% | ||
| -$112.29M-18.7% | -$106.08M-22.2% | -$106.35M-28.1% | -$101.25M-25.8% | -$94.61M-20.6% | ||
| $100K+17.6% | $107K-5.3% | $116K-48.7% | $133K-27.3% | $85K-53.6% | ||
| -$112.39M-18.7% | -$106.19M-22.2% | -$106.47M-27.9% | -$101.38M-25.6% | -$94.7M-20.4% | ||
| -$1.74+8.4% | -$1.79-2.3% | -$1.94-12.1% | -$1.96-9.5% | -$1.90-2.2% | ||
| -$117.48M-15.6% | -$111.63M-17.6% | -$112.18M-22.1% | -$107.51M-20.8% | -$101.65M-17.5% | ||
| -$118.62M-15.4% | -$112.79M-17.4% | -$113.36M-21.8% | -$108.69M-20.3% | -$102.84M-17.0% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Is Aura Biosciences, Inc. profitable?
- Aura Biosciences, Inc. is not currently profitable: it reported a net loss of $112.4M over the trailing twelve months.
- What is Aura Biosciences, Inc.'s earnings per share?
- Aura Biosciences, Inc.'s diluted EPS over the trailing twelve months is $-1.74.
- Where does Aura Biosciences, Inc.'s income statement data come from?
- Every line is extracted from Aura Biosciences, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.